1. Home
  2. LEGN vs ALGM Comparison

LEGN vs ALGM Comparison

Compare LEGN & ALGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • ALGM
  • Stock Information
  • Founded
  • LEGN 2014
  • ALGM 1990
  • Country
  • LEGN United States
  • ALGM United States
  • Employees
  • LEGN N/A
  • ALGM N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • ALGM Semiconductors
  • Sector
  • LEGN Health Care
  • ALGM Technology
  • Exchange
  • LEGN Nasdaq
  • ALGM Nasdaq
  • Market Cap
  • LEGN 6.3B
  • ALGM 6.8B
  • IPO Year
  • LEGN 2020
  • ALGM 2020
  • Fundamental
  • Price
  • LEGN $32.30
  • ALGM $30.78
  • Analyst Decision
  • LEGN Strong Buy
  • ALGM Strong Buy
  • Analyst Count
  • LEGN 12
  • ALGM 8
  • Target Price
  • LEGN $70.82
  • ALGM $35.38
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • ALGM 2.4M
  • Earning Date
  • LEGN 11-11-2025
  • ALGM 10-30-2025
  • Dividend Yield
  • LEGN N/A
  • ALGM N/A
  • EPS Growth
  • LEGN N/A
  • ALGM N/A
  • EPS
  • LEGN N/A
  • ALGM N/A
  • Revenue
  • LEGN $796,838,000.00
  • ALGM $761,492,000.00
  • Revenue This Year
  • LEGN $70.27
  • ALGM $20.09
  • Revenue Next Year
  • LEGN $50.28
  • ALGM $18.42
  • P/E Ratio
  • LEGN N/A
  • ALGM N/A
  • Revenue Growth
  • LEGN 74.75
  • ALGM N/A
  • 52 Week Low
  • LEGN $27.34
  • ALGM $16.38
  • 52 Week High
  • LEGN $47.79
  • ALGM $38.45
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 45.99
  • ALGM 57.07
  • Support Level
  • LEGN $31.44
  • ALGM $30.00
  • Resistance Level
  • LEGN $32.59
  • ALGM $32.19
  • Average True Range (ATR)
  • LEGN 1.36
  • ALGM 1.37
  • MACD
  • LEGN 0.11
  • ALGM 0.30
  • Stochastic Oscillator
  • LEGN 37.97
  • ALGM 77.29

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About ALGM Allegro MicroSystems Inc.

Allegro Microsystems Inc is a designer, developer, fabless manufacturer, and marketer of sensor ICs and application-specific analog power ICs for automotive and industrial markets. Its Sensor IC allows customers to precisely measure motion, speed, position, and current, and Power ICs include high-temperature and high-voltage capable motor drivers, power management, and LED driver ICs. Its products are divided into three categories such as SENSE which includes Current Sensors, Switches and Latches, and Interface ICs among others; REGULATE which includes Regulators, ClearPower Modules, and LED Drivers; and DRIVE which includes BLDC Drivers, Brush DC, and others. Key revenue for the company is generated from Greater China and the rest from the United States, Japan, Europe, and other regions.

Share on Social Networks: